Geneos Wealth Management’s First Trust Enhanced Short Maturity ETF FTSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.16M Buy
69,589
+23,573
+51% +$1.41M 0.08% 250
2026
Q1
$2.75M Sell
46,016
-4,671
-9% -$280K 0.06% 314
2025
Q4
$3.04M Buy
50,687
+17,147
+51% +$1.03M 0.07% 287
2025
Q3
$2.01M Buy
33,540
+1,667
+5% +$100K 0.05% 347
2025
Q2
$1.91M Buy
31,873
+9,610
+43% +$576K 0.05% 378
2025
Q1
$1.33M Buy
22,263
+3,416
+18% +$205K 0.04% 388
2024
Q4
$1.13M Buy
+18,847
New +$1.13M 0.04% 391
2022
Q1
Sell
-67,755
Closed -$4.05M 2832
2021
Q4
$4.05M Sell
67,755
-1,853
-3% -$111K 0.15% 151
2021
Q3
$4.17M Sell
69,608
-2,437
-3% -$146K 0.16% 150
2021
Q2
$4.32M Sell
72,045
-17,653
-20% -$1.06M 0.17% 142
2021
Q1
$5.38M Sell
89,698
-10,247
-10% -$615K 0.15% 161
2020
Q4
$5.01M Sell
99,945
-18,609
-16% -$1.12M 0.2% 120
2020
Q3
$7.15M Buy
118,554
+3,534
+3% +$212K 0.37% 58
2020
Q2
$6.9M Buy
115,020
+3,080
+3% +$184K 0.38% 62
2020
Q1
$6.67M Buy
111,940
+8,324
+8% +$498K 0.45% 49
2019
Q4
$6.22M Sell
103,616
-21,928
-17% -$1.32M 0.33% 75
2019
Q3
$7.55M Buy
125,544
+13,108
+12% +$788K 0.45% 44
2019
Q2
$6.75M Buy
112,436
+42,875
+62% +$2.58M 0.42% 54
2019
Q1
$4.17M Sell
69,561
-3,993
-5% -$239K 0.28% 95
2018
Q4
$4.4M Sell
73,554
-31,159
-30% -$1.87M 0.33% 78
2018
Q3
$6.28M Buy
104,713
+13,338
+15% +$801K 0.42% 51
2018
Q2
$5.55M Buy
91,375
+85,334
+1,413% +$5.12M 0.43% 57
2018
Q1
$362K Buy
6,041
+2,184
+57% +$131K 0.03% 377
2017
Q4
$231K Buy
3,857
+760
+25% +$45.6K 0.02% 496
2017
Q3
$185K Hold
3,097
0.02% 527
2017
Q2
$185K Buy
3,097
+167
+6% +$10K 0.02% 517
2017
Q1
$175K Buy
2,930
+2,350
+405% +$141K 0.02% 516
2016
Q4
$34K Buy
+580
New +$34.8K ﹤0.01% 974

Other funds holding FTSM

Geneos Wealth Management's FTSM Position: Q2 2026 in Review

Geneos Wealth Management increased its First Trust Enhanced Short Maturity ETF (FTSM) stake by 51% in Q2 2026, buying an estimated $1.41M and bringing the position to 69,589 shares worth $4.16M. The position accounts for 0.08% of the portfolio, ranked #250.

Geneos Wealth Management first reported a position in FTSM in Q4 2016 and has held it in 28 quarters since. The position peaked at $7.55M in Q3 2019. 425 funds tracked by Wall St. Rank hold FTSM as of Q2 2026.

  • Geneos Wealth Management held 69,589 shares of First Trust Enhanced Short Maturity ETF worth $4.16M as of Q2 2026.
  • Geneos Wealth Management bought 23,573 First Trust Enhanced Short Maturity ETF shares in Q2 2026, an estimated $1.41M.
  • First Trust Enhanced Short Maturity ETF made up 0.08% of Geneos Wealth Management's portfolio in Q2 2026, its #250 holding.
  • Geneos Wealth Management first reported a position in First Trust Enhanced Short Maturity ETF in Q4 2016 and has held it in 28 quarters since.
  • Geneos Wealth Management's First Trust Enhanced Short Maturity ETF position peaked at $7.55M in Q3 2019.
  • 425 funds tracked by Wall St. Rank held First Trust Enhanced Short Maturity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.